IP Library Granted Patent US 7,897,727
Granted Patent B2
US 7,897,727 · App. 12/398,534 · Granted Mar 1, 2011

Bioactive peptide for cell adhesion

Assignee: University of Delaware
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,897,727
App. No.
12/398,534
Granted
Mar 1, 2011
Kind
B2
Abstract

Implantable devices for adhering eukaryotic cells and devices providing a substrate for eukaryotic cell growth and/or differentiation in vitro are described. Each device comprises a scaffold that is coated with a protein comprising an adhesive polypeptide that has at least 90% sequence identity to a specific peptide sequence within domain IV of perlecan. The devices adhere epithelial cells, epithelial stem cells, mesenchymal stem cells, and osteoblasts.

Claims (15)

1. An implantable device for adhering eukaryotic cells, the device comprising a scaffold coated with an isolated polypeptide, wherein said polypeptide is at least 90% identical to SEQ ID NO: 1 and exhibits adhesiveness to the eukaryotic cells, and wherein the scaffold comprises a synthetic polymer, a ceramic, a metal or combinations thereof.

2. The device of claim 1 , wherein the polypeptide is attached to the scaffold by a linker.

3. The device of claim 2 , wherein the linker is selected from the group consisting of bovine serum albumin, fibronectin, and collagen.

4. The device of claim 2 , wherein the linker is selected from the group consisting of polyamides, polypeptides, polyesters, polycarbonates, polyurethanes, polyacetals, polysaccharides, and polyolefins.

5. The device of claim 2 , wherein the linker is polylysine or polyalanine.

6. The device of claim 1 , wherein the eukaryotic cells are selected from the group consisting of epithelial cells, epithelial stem cells, mesenchymal stem cells, and osteoblasts.

7. The device of claim 1 , wherein the implanted device does not induce an inflammatory response.

8. The device of claim 1 , wherein the polypeptide is phosphorylated.

9. A device providing a substrate for eukaryotic cell growth in vitro, the device comprising a scaffold coated with an isolated polypeptide, said polypeptide is at least 90% identical to SEQ ID NO: 1 and exhibits adhesiveness to the eukaryotic cells, wherein the polypeptide adheres the eukaryotic cells and provides support for eukaryotic cell replication and/or differentiation, and wherein the scaffold comprises a synthetic polymer, a ceramic, a metal or combinations thereof.

10. The device of claim 9 , wherein the polypeptide is attached to the scaffold by a linker.

11. The device of claim 10 , wherein the linker is selected from the group consisting of bovine serum albumin, fibronectin, and collagen.

12. The device of claim 10 , wherein the linker is selected from the group consisting of polyamides, polypeptides, polyesters, polycarbonates, polyurethanes, polyacetals, polysaccharides, and polyolefins.

13. The device of claim 10 , wherein the linker is polylysine or polyalanine.

14. The device of claim 9 , wherein the eukaryotic cells are selected from the group consisting of epithelial cells, epithelial stem cells, mesenchymal stem cells, and osteoblasts.

15. The device of claim 9 , wherein the polypeptide is phosphorylated.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 4, 2021
From: UNIVERSITY OF DELAWARE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 058024/0700 →
Continuity (4)
Division 10363376
Provisional Application 60229222 · Aug 31, 2000
Provisional Application 60309209 · Aug 1, 2001
Related Publication 20090239304A1 · Sep 24, 2009